Serum kinetics of metronidazole and tinidazole were compared in four separate randomized crossover studies. Single doses of each drug were given to healthy volunteers through intravenous infusion (500 mg over 20 min, six persons), by mouth (500 mg, nine persons), by rectum (1,000 mg, six persons), or intravaginally (500 mg, six persons). Concentrations of the unchanged drugs in serum, measured by high-pressure liquid chromatography, were similar after oral and intravenous administration, with mean peaks of 9.0 and 9.4 Fg/ml for metronidazole and 7.5 and 10.1 ,ug/ml for tinidazole. Concentrations of tinidazole were significantly higher than those of metronidazole from 4 h onwards after intravenous infusion, and from 3 h onwards after administration by mouth. After rectal administrations, a significant difference was seen only at 48 h. After vaginal dosing, however, concentrations of metronidazole were significantly higher than those of tinidazole between 1.5 and 12 h. Bioavailability of either drug, calculated according to the formula (area under the curve for oral administration)/(area under the curve for infusion), was practically complete after oral administration and was poorer after rectal and especially vaginal administration. Whenever the parameters were calculable, the elimination half-life of tinidazole (range of means, 14.0 to 14.7 h) was significantly longer and total clearance (40.3 to 47.6 ml/min) was lower than the corresponding values of metronidazole (7.9 to 8.8 h and 71.8 to 80.1 ml/min, respectively).
Serum kinetics of metronidazole and tinidazole were compared in four separate randomized crossover studies. Single doses of each drug were given to healthy volunteers through intravenous infusion (500 mg over 20 min, six persons), by mouth (500 mg, nine persons), by rectum (1,000 mg, six persons), or intravaginally (500 mg, six persons). Concentrations of the unchanged drugs in serum, measured by high-pressure liquid chromatography, were similar after oral and intravenous administration, with mean peaks of 9.0 and 9.4 Fg/ml for metronidazole and 7.5 and 10.1 ,ug/ml for tinidazole. Concentrations of tinidazole were significantly higher than those of metronidazole from 4 h onwards after intravenous infusion, and from 3 h onwards after administration by mouth. After rectal administrations, a significant difference was seen only at 48 h. After vaginal dosing, however, concentrations of metronidazole were significantly higher than those of tinidazole between 1.5 and 12 h. Bioavailability of either drug, calculated according to the formula (area under the curve for oral administration)/(area under the curve for infusion), was practically complete after oral administration and was poorer after rectal and especially vaginal administration. Whenever the parameters were calculable, the elimination half-life of tinidazole (range of means, 14.0 to 14.7 h) was significantly longer and total clearance (40.3 to 47.6 ml/min) was lower than the corresponding values of metronidazole (7. 9 to 8.8 h and 71.8 to 80.1 ml/min, respectively).
Metronidazole and tinidazole have been used for some years as antiprotozoal drugs for prevention, and more recently for treatment, of infections with anaerobic bacteria (2, 3) . The doses of these two drugs recommended for use against anaerobic infections are essentially the same and are much lower than those used for protozoal infections. There have been comprehensive comparisons of pharmacokinetics of metronidazole and tinidazole after oral ingestion (13, 14, 16) , but there are not such studies related to intravenous, intrarectal, or intravaginal delivery, even though these compounds are also administered by these routes. The pharmacokinetics of metronidazole and tinidazole appeared to be different in isolated studies (4-6, 13a) . The use of different assay procedures may have biased these results (10) .
This report deals with a comparison of study design of serum kinetics of metronidazole and tinidazole administered via oral, intravenous, rectal, or vaginal routes to healthy volunteers at doses currently recommended for anaerobic infections. The concentrations of both drugs were analyzed by a high-pressure liquid chromatography method specific for unchanged metronidazole and tinidazole. An intravenous infusion of 500 mg of metronidazole (Flagyl, 5 mg/ml, Rh6ne-Poulenc) and tinidazole (Tricanix, 5 mg/ml, Neofarma) was given at a constant rate over 20 min, using an infusion pump (Extracorporeal ANTIMICROB. AGENTS CHEMOTHER. b Five subjects were the same ones in the infusion study. model 2102). One tablet each of metronidazole (Elyzol, 500-mg tablet, Dumex) and tinidazole (Tricanix, 500-mg tablet, Neofarma) was ingested with 100 ml of water. The rectal doses were 1 g of metronidazole (Flagyl, 1-g suppository, Rh6ne-Poulenc) and 1 g of tinidazole (Tricanix, 500-mg suppository/vagitorium, Neofarma). The vaginal dose was 500 mg (Flagyl, vagitorium, or Tricanix, 500 mg suppository/vagitorium).
All treatments were given after an overnight fast. Eating was permitted 3 
RESULTS
The mean serum concentrations of metronidazole and tinidazole administered by different routes are recorded in Fig. 1, 2 , and 3. The main pharmacokinetic parameters derived from these serum concentrations are shown in Table 2 . Drugs administered intravenously. The serum concentrations of tinidazole were significantly higher than those of metronidazole only at 4 h and onwards (Fig. 1) . The calculated tV2 (14.0 ± 0.7 h, mean ± standard error of the mean
[SEM]), the apparent Vd (57.0 ± 1.7 liters), and AUC°" (175.8 ± 12.7 ,ug * h/ml) of tinidazole exceeded significantly the corresponding parameters of metronidazole (7.9 ± 0.6 h, 53.2 ± 1.2 liters, and 106.9 ± 10.7 ,ug -h/ml, respectively), whereas the opposite was true for serum clearance (Table 2 ). Drugs administered oraily. The Cm.., and subsequent serum concentrations were statistically significantly higher after tinidazole administration than after metronidazole (Fig. 2) . The tV2 of tinidazole (14.7 ± 0.7 h) was significantly longer than that of metronidazole (8.9 ± 0.6 h). The Vd of tinidazole (50.7 ± 2.2 liters) exceeded significantly that of metronidazole (38.9 ± 3.6 liters).
'The Vd of metronidazole was significantly smallGr after oral (38.9 ± 3.6 liters) than after intravenous administration (53.2 ± 1.2 liters). The apparent bioavailabilities of the tablets according to AUCOrF,/AUCif.,USiOn x 100 in five subjects who took part in both studies were 125 and 111% for tinidazole and metronidazole, respectively. Drugs admintered ctafly. There was a significant difference between the serum concentrations of metronidazole and tinidazole only at 48 h (Fig. 3) . The t1/2 of tinidazole was significantly longer than that of metronidazole ( Table  2 ). The average absorptions of tinidazole and metronidazole from rectum were about 39 and 53%, respectively, corrected for dose and calculated by comparing the AUC values after rectal and oral administrations to the separate groups of volunteers.
Drugs administered vagilnaly. Cma,,, and AUC values of both drugs were only a fraction of the corresponding values after other routes of administration (Table 2) . Compared with oral dosing, only about 10 and 25% of the intravaginal tinidazole and metronidazole, respectively, was absorbed on the average. Serum levels of metronidazole were significantly higher than those of tinidazole from 1.5 h onwards (Fig. 3) .
DISCUSSION
Because the microbiological properties of metronidazole and tinidazole are rather simiar (2, 3), a direct comparison of their concentrations is feasible. There was no significant difference between the C. values of metronidazole and tinidazole after intravenous and oral administrations. Considering the dose, the peak levels were similar to or somewhat lower than those previously reported (1, 4-6, 13, 14, 16) . Calculations on the basis of corresponding AUC values indicated complete absorption of both drugs after oral administration. Several factors may contribute to apparent bioavailability values exceeding 100%. Nitroimidazoles were given not as a bolus injection but as a 20-min infusion. Even during the short infusion, these drugs were rapidly distributed in tissues (13a); metabolism also can occur. Another possibility is intestinal reabsorption of nitroimidazoles. This may exaggerate the concentrations of nitroimidazoles in serum after oral administration. No approximations were done to correct the influence of these shifts. With these reservations, our results are keeping with the reports on the 90 to 108% bioavailabilities of metronidazole and tinidazole (3, 9) .
Considering the different dose, the absorption upon rectal administration was about one-half or even less of that upon oral administration. A similar rectal absorption of metronidazole was reported by others (10, 11) . Conversely, Bergan and Arnold (1) and loannides et al. (7) reported a good bioavailability of metronidazole after a rectal dose. Our results are in accordance with those of Bergan and Arnold (1) in the sense that the variation in serum levels between volunteers was much greater after rectal than after oral administration.
After vaginal administration, the serum levels of tinidazole were significantly lower than metronidazole levels, possibly owing to the fact that tinidazole was given as a rectal suppository and not as a specifically aimed vagitorium, as was metronidazole. However, the serum concentrations of both nitroimidazoles remained clearly inferior to those yielded by other dosage forms. Hence, the vaginal nitroimidazoles exerted mainly a local action.
Our results confirmed earlier findings about the significantly slower rate of elimination of tinidazole compared with that of metronidazole (4, 6, 9, 13, 14, 16) . The elimination half-life of tinidazole was significantly longer, and plasma clearance was lower, than the corresponding parameters of metronidazole. Serum tinidazole levels remained above 3 Itg/ml (90% minimal inhibitory concentration value for most anaerobes [3] ) for at least 24 h after oral and rectal administrations. After intravenous infusion, the mean concentration was marginally below 3 ,ug/ml as late as 23 h. Conversely, the metronidazole concentrations remained above 3 .tg/ml for no longer than 12 h after enteral administration and only 8 h after the infusion. Accordingly, in the studies of Wood and Monro (16) , the average tinidazole concentrations were three and five times higher than those of metronidazole at 24 and 48 h, respectively.
Metronidazole and tinidazole are currently recommended and used at doses of 400 to 500 mg orally or intravenously and 1 g rectally, two or three times daily. It appears that the three times daily dose schedule is appropriate for metronidazole. In the case of tinidazole, either smaller doses or less frequent administrations seem justified. This view is supported by the efficient tissue penetration of tinidazole, which has been substantiated in earlier studies in which actual tissue concentrations have been measured. In several key tissues and serum, the tinidazole levels were nearly identical after a single intravenous dose (12, 13a, 15) . In the present study, the superior tissue distribution of tinidazole over metronidazole was seen as a larger apparent volume of distribution.
